• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by The Pennant Group Inc.

    7/7/25 4:50:48 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care
    Get the next $PNTG alert in real time by email
    S-8 1 pntgforms-82025.htm S-8 Document

    Registration No. 333-

    As filed with the Securities and Exchange Commission on July 7, 2025
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    _____________________
    FORM S-8
    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933
    _____________________
    The Pennant Group, Inc.
    (Exact name of registrant as specified in its charter)
    Delaware83-3349931
    (State or other jurisdiction(IRS Employer Identification No.)
    of incorporation or organization)
    1675 E Riverside Drive, Suite 150,
    Eagle, ID 8361629222 Rancho Viejo Road, Suite 127
    Eagle, ID 83616
    (Address of principal executive offices and Zip Code)
    _____________________

    The Amended and Restated Pennant Group, Inc. 2019 Omnibus Incentive Plan
    (Full title of the plan)
    Kirk S. CheneyWith a copy to:
    General Counsel
    The Pennant Group, Inc.
    1675 E Riverside Drive, Suite 150
    Eagle, ID 83616
    (Name and Address of agent for service)
    Amy Bowler
    Holland & Hart LLP
    555 17th Street, Suite 3200
    Denver, Colorado 80202
    (303) 295-8000
    (208) 506-6100
    (Telephone number, including area code, of agent for service)
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
    Large accelerated filer o Accelerated filer
    Non-accelerated filer o (Do not check if a smaller reporting company) Smaller reporting company o
    Emerging growth company o

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. o



    INTRODUCTORY STATEMENT

    The Pennant Group, Inc. (the “Registrant” or the “Company”) is filing this Registration Statement on Form S-8 for the purpose of registering 3,275,000 shares of its common stock, par value $0.001 per share (the “Common Stock”), issuable pursuant to the terms of the Company’s Amended and Restated 2019 Omnibus Incentive Plan (the “Amended and Restated Plan”). Such shares of Common Stock are being registered in addition to 9,000,000 shares registered on Form S-8 File No. 333-233937 filed with the Commission (defined below) on September 25, 2019 (the “Prior Registration Statement”).

    This Registration Statement relates to securities of the same class as to which the Prior Registration Statement relates and is submitted in accordance with General Instruction E to Form S-8 regarding Registration of Additional Securities. Pursuant to General Instruction E of Form S-8, the contents of the Prior Registration Statement, to the extent relating to the registration of Common Stock issuable under the Amended and Restated Plan, is incorporated herein by reference and made part of this Registration Statement, except to the extent amended hereby.

    PART I

    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

    Item 1. Plan Information.*
    Item 2. Registrant Information and Employee Plan Annual Information.*
    * The documents containing the information specified in Part I will be sent or given to participants in the Amended and Restated Plan as specified by Rule 428(b)(1) under the Securities Act of 1933, as amended (the “Securities Act”). In accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the “Commission”) and the instructions to Part I of Form S-8, such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act. These documents and the documents incorporated by reference pursuant to Item 3 of Part II of this Registration Statement, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.

    PART II

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

    Item 3. Incorporation of Documents by Reference.
    We “incorporate by reference” in this prospectus certain documents that we have previously filed with the Commission. This means that we are disclosing important information to you without actually including that information in this prospectus by referring you to other documents that we have filed separately with the Commission. The information incorporated by reference is an important part of this prospectus. Information that we later provide to the Commission, and which is deemed “filed” with the Commission, will automatically update information that we previously filed with the Commission, and replace information in this prospectus and information that we previously filed with the Commission.

    The Registrant hereby incorporates by reference into this Registration Statement the following documents, which have been filed with the Commission:

    (a)    the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the Commission on February 27, 2025 (including the portions of the Registrant's Definitive Proxy Statement for the Registrant's 2025 Annual Meeting of Stockholders incorporated by reference therein);




    (b)    the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, filed with the Commission on May 6, 2025;

    (c)     the Registrant’s Current Reports on Form 8-K filed with the Commission on February 27, 2025, May 1, 2025, May 6, 2025, and May 20, 2025; and

    (d)    The description of the Registrant's common stock contained in the Registrant's Registration Statement on Form 10 filed with the Commission on September 3, 2019, including any amendments or reports filed for the purpose of updating such description (including Exhibit 4.1 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the Commission on February 27, 2025).

    All reports and definitive proxy or information statements filed pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) after the date of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing of such documents. The Registrant expressly excludes from such incorporation information furnished pursuant to Item 2.02 or Item 7.01 of any Current Report on Form 8-K. Any document or any statement contained in a document incorporated or deemed to be incorporated herein by reference shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a subsequently filed document or a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated herein by reference modifies or supersedes such document or such statement. Any such document or statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

    You should rely only on the information contained or incorporated by reference in this prospectus or any applicable prospectus supplement we may authorize to be delivered to you. You should not assume that the information incorporated by reference or provided in this prospectus, or any applicable prospectus supplement is accurate as of any date other than the date on the front of each document.

    Item 4. Description of Securities.
    Not Applicable.
    Item 5. Interests of Named Experts and Counsel.
    Not Applicable.
    Item 6. Indemnification of Directors and Officers.
    Our amended and restated certificate of incorporation provides that we shall indemnify our directors and officers to the fullest extent permitted by law. Our amended and restated certificate of incorporation also provides that, pursuant to Delaware law, our directors shall not be liable for monetary damages for breach of the directors’ fiduciary duty of care to us and our stockholders. This provision in our amended and restated certificate of incorporation does not eliminate the duty of care, and in appropriate circumstances equitable remedies such as injunctive or other forms of non-monetary relief will remain available under Delaware law. In addition, each director is subject to liability for breach of the director’s duty of loyalty to us for acts or omissions not in good faith or involving intentional misconduct, for knowing violations of law, for actions leading to improper personal benefit to the director, and for payment of dividends or approval of stock repurchases or redemptions that are unlawful under Delaware law. The provision also does not affect a director’s responsibilities under any other law, such as the federal securities laws or state or federal environmental laws. Our amended and restated certificate of incorporation further provides that we are authorized to indemnify our directors and officers to the fullest extent permitted by law through the bylaws, agreement, vote of stockholders or disinterested directors, or otherwise.




    We have entered into agreements to indemnify our directors, officers and other key employees in addition to the indemnification provided for in our amended and restated certificate of incorporation and bylaws. These agreements, among other things, indemnify these persons for certain expenses (including attorneys’ fees), judgments, fines and settlement amounts incurred by such person in any action or proceeding, including any action by or in our right, on account of services by that person as a director or officer or as a director or officer of any of our subsidiaries, or as a director or officer of any other company or enterprise that the person provides services to at our request.

    We maintain directors’ and officers’ liability insurance for our officers and directors.

    Item 7. Exemption from Registration Claimed.
    Not Applicable.
    Item 8. Exhibits.
    Exhibit No.DescriptionWhere Located
    4.1
    Amended and Restated Certificate of Incorporation of The Pennant Group, Inc., effective as of September 27, 2019Incorporated by reference to Exhibit 3.1 to The Pennant Group, Inc.’s Current Report on Form 8-K filed with the SEC on October 3, 2019
    4.3
    Second Amended and Restated Bylaws of The Pennant Group, Inc., effective as of February 21, 2022Incorporated by reference to Exhibit 3.1 to The Pennant Group, Inc.’s Current Report on Form 8-K filed with the SEC February 22, 2022
    4.5
    The Pennant Group, Inc. Amended and Restated 2019 Omnibus Incentive PlanFiled herewith
    5.1
    Opinion of Holland & Hart LLP
    Filed herewith
    23.1
    Consent of Deloitte & Touche LLP
    Filed herewith
    23.2
    Consent of Holland & Hart LLP (contained in Exhibit 5.1 to this Registration Statement)
    Filed herewith
    24.1
    Power of Attorney (included in the signature page to this Registration Statement)
    Filed herewith
    107
    Filing Fee Table
    Filed herewith

    Item 9. Undertakings.
    (a) The undersigned registrant hereby undertakes:
     
    (1) to file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
     
    (i) to include any prospectus required by Section 10(a)(3) of the Securities Act;
     
    (ii) to reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) under the Securities Act if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective Registration Statement; and




    (iii) to include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;
     
    provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the Registration Statement is on Form S-8, and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement;

    (2) that, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; and
     
    (3) to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
     
    (b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
     
    (c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

    SIGNATURES
    Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Eagle, State of Idaho on July 7, 2025.

    THE PENNANT GROUP, INC.
    By:/s/ Brent J. Guerisoli
    Brent J. Guerisoli
    Chief Executive Officer and Chairman of the Board









    POWER OF ATTORNEY

    KNOW ALL MEN BY THESE PRESENTS that each of the undersigned officers and directors does hereby constitute and appoint Kirk S. Cheney, or his substitute or substitutes, as his or her true and lawful attorneys-in-fact and agents, with full power and authority to do any and all acts and things and to execute and file or cause to be filed any and all instruments, documents or exhibits which said attorney and agent, determine may be necessary or advisable or required to enable said corporation to comply with the Securities Act and any rules or regulations or requirements of the Commission in connection with this Registration Statement. Without limiting the generality of the foregoing power and authority, the powers granted include the power and authority to sign the names of the undersigned officers and directors in the capacities indicated below to this Registration Statement, to any and all amendments, both pre-effective and post-effective, and supplements to this Registration Statement and to any and all instruments, documents or exhibits filed as part of or in conjunction with this Registration Statement or amendments or supplements thereof, with the powers of substitution and revocation, and each of the undersigned hereby ratifies and confirms all that said attorney and agent, or his substitute or substitutes, shall lawfully do or cause to be done by virtue hereof. In witness whereof, each of the undersigned has executed this Power of Attorney as of the dates indicated below.

    Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated below.
    SignatureTitleDate
    /s/ Brent J. GuerisoliChief Executive Officer and Chairman of the BoardJuly 7, 2025
    Brent J. Guerisoli
    /s/ Barry M. Smith
    Director
    July 7, 2025
    Barry M. Smith
    /s/ Christopher R. Christensen
    Director
    July 7, 2025
    Christopher R. Christensen
    /s/ John G. Nackel, Ph.D.DirectorJuly 7, 2025
     John G. Nackel, Ph.D.
    /s/ Stephen M. R. CoveyDirectorJuly 7, 2025
    Stephen M. R. Covey
    /s/ Scott E. LambDirectorJuly 7, 2025
     Scott E. Lamb
    /s/ Gregory K. MorrisDirectorJuly 7, 2025
     Gregory K. Morris
    /s/ Suzanne D. SnapperDirectorJuly 7, 2025
    Suzanne D. Snapper


    Get the next $PNTG alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $PNTG

    DatePrice TargetRatingAnalyst
    12/19/2024$33.00Equal Weight
    Wells Fargo
    1/5/2024$14.00 → $18.00Equal-Weight → Overweight
    Stephens
    2/27/2023$15.00 → $16.00Hold → Buy
    Stifel
    8/25/2022$22.00Outperform
    Oppenheimer
    6/21/2022$23.00 → $17.00Overweight → Equal-Weight
    Stephens
    3/10/2022$37.00 → $26.00Outperform
    RBC Capital
    3/2/2022$33.00 → $26.00Overweight
    Stephens & Co.
    3/1/2022$32.00 → $18.00Buy → Hold
    Stifel
    More analyst ratings

    $PNTG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Nackel John G. was granted 1,900 shares, increasing direct ownership by 1% to 166,965 units (SEC Form 4)

      4 - Pennant Group, Inc. (0001766400) (Issuer)

      7/17/25 4:16:45 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Director Morris Gregory K Sr. was granted 1,900 shares, increasing direct ownership by 7% to 29,700 units (SEC Form 4)

      4 - Pennant Group, Inc. (0001766400) (Issuer)

      7/17/25 4:16:38 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Director Snapper Suzanne D. was granted 1,900 shares, increasing direct ownership by 0.86% to 222,764 units (SEC Form 4)

      4 - Pennant Group, Inc. (0001766400) (Issuer)

      7/17/25 4:16:32 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care

    $PNTG
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $PNTG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Pennant Announces Home Health Acquisition in Southern California

      EAGLE, Idaho, July 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of a premier home health agency, GrandCare Health Services. The newly acquired agency, to be known as GrandCare Home Health, provides services in Los Angeles, Orange, Riverside and San Diego counties in California, and broadens Pennant's service area in the region. "We are happy to welcome GrandCare Home Health to Pennant," said Brent Guerisoli, Chief Executive Officer of Pennant. "This acquisition expands our ability to provide home health services to communitie

      7/1/25 4:44:55 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • CareTrust REIT Positions for Continued Growth with New $500 Million Term Loan and New Hires

      CareTrust REIT, Inc. (NYSE:CTRE) ("CareTrust") announced today the closing of a new senior unsecured term loan and the hiring of two talented real estate professionals. These actions further bolster its growth platform and strengthen the Company's long-term prospects at a time of accelerating investment in its healthcare portfolio. New Term Loan The Company closed on an amendment to its existing credit agreement with KeyBank National Association and a syndicate of leading financial institutions to add a new $500 million unsecured term loan (the "Term Loan") to its existing $1.2 billion unsecured revolving credit facility. The Company currently expects to use borrowings under the Term Lo

      6/2/25 6:30:00 AM ET
      $CTRE
      $ENSG
      $PNTG
      Real Estate Investment Trusts
      Real Estate
      Hospital/Nursing Management
      Health Care
    • The Pennant Group Appoints Suzanne Snapper as Director

      EAGLE, Idaho, May 16, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced the appointment of Suzanne D. Snapper to its board of directors following her election by a vote of shareholders in connection with the Company's annual shareholder meeting. Ms. Snapper is the Chief Financial Officer of the Ensign Group, Inc. ("Ensign") (NASDAQ:ENSG), a leading publicly-traded provider of skilled nursing services. In this role, which Ms. Snapper has held since 2009, Ms. Snapper is responsible for Ensign's accounting, finance, information technology, tax, internal contro

      5/16/25 12:12:47 PM ET
      $ENSG
      $PNTG
      Hospital/Nursing Management
      Health Care
      Medical/Nursing Services
    • Wells Fargo initiated coverage on Pennant Group with a new price target

      Wells Fargo initiated coverage of Pennant Group with a rating of Equal Weight and set a new price target of $33.00

      12/19/24 8:23:12 AM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Pennant Group upgraded by Stephens with a new price target

      Stephens upgraded Pennant Group from Equal-Weight to Overweight and set a new price target of $18.00 from $14.00 previously

      1/5/24 8:40:53 AM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Pennant Group upgraded by Stifel with a new price target

      Stifel upgraded Pennant Group from Hold to Buy and set a new price target of $16.00 from $15.00 previously

      2/27/23 7:37:38 AM ET
      $PNTG
      Medical/Nursing Services
      Health Care

    $PNTG
    Leadership Updates

    Live Leadership Updates

    See more
    • The Pennant Group Appoints Suzanne Snapper as Director

      EAGLE, Idaho, May 16, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced the appointment of Suzanne D. Snapper to its board of directors following her election by a vote of shareholders in connection with the Company's annual shareholder meeting. Ms. Snapper is the Chief Financial Officer of the Ensign Group, Inc. ("Ensign") (NASDAQ:ENSG), a leading publicly-traded provider of skilled nursing services. In this role, which Ms. Snapper has held since 2009, Ms. Snapper is responsible for Ensign's accounting, finance, information technology, tax, internal contro

      5/16/25 12:12:47 PM ET
      $ENSG
      $PNTG
      Hospital/Nursing Management
      Health Care
      Medical/Nursing Services
    • The Pennant Group Appoints Brent Guerisoli as Chairman and Scott Lamb as Lead Independent Director

      EAGLE, Idaho, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice, and senior living companies, today announced the appointment of Brent Guerisoli as Chairman of its board of directors and Scott Lamb as Lead Independent Director of its board of directors, each effective January 1, 2025. Mr. Guerisoli and Mr. Lamb are existing directors of the Company. Mr. Guerisoli has served on Pennant's board since 2023. He has been a key leader with the organization since 2012 and has served as its Chief Executive Officer since 2022. Mr. Guerisoli succeeds Barry Smith, who served as Chairman since February 2

      1/2/25 4:23:29 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • The Pennant Group Appoints Lynette Walbom as Chief Financial Officer

      EAGLE, Idaho, May 22, 2023 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced that its Board of Directors has appointed Lynette Walbom as Chief Financial Officer effective May 22, 2023. Before joining Pennant, Ms. Walbom was Vice President of Financial Reporting & Tax for Raising Cane's Restaurants, LLC, a national restaurant chain operating in 35 states, which more than doubled in size—based on number of restaurants and geographic footprint—during her tenure. At Raising Cane's, Ms. Walbom had broad responsibility for financial reporting, acquisitions, tax, accou

      5/22/23 4:05:00 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care

    $PNTG
    Financials

    Live finance-specific insights

    See more
    • Pennant Announces Home Health Acquisition in Southern California

      EAGLE, Idaho, July 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of a premier home health agency, GrandCare Health Services. The newly acquired agency, to be known as GrandCare Home Health, provides services in Los Angeles, Orange, Riverside and San Diego counties in California, and broadens Pennant's service area in the region. "We are happy to welcome GrandCare Home Health to Pennant," said Brent Guerisoli, Chief Executive Officer of Pennant. "This acquisition expands our ability to provide home health services to communitie

      7/1/25 4:44:55 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Pennant Reports First Quarter 2025 Results

      EAGLE, Idaho, May 06, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.22 for the first quarter of 2025. Pennant also reported adjusted diluted earnings per share of $0.27 for the quarter(1). First Quarter Highlights Total revenue for the first quarter was $209.8 million, an increase of $52.9 million or 33.7% over the prior year quarter;Net income for the first quarter was $7.8 million, an increase of $2.9 million or 58.5% over the prior year quarter;Adjusted net income

      5/6/25 4:08:00 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Pennant Expands Portfolio with Acquisition of Senior Living Community in Arizona

      EAGLE, Idaho, April 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of the real estate and operations of an established senior living community in Arizona. The newly acquired community offers assisted living and memory care services, and increases Pennant's Arizona operations by 128 units. "This acquisition aligns with our mission to provide life-changing service as we create active, supportive communities where seniors can thrive," said Brent Guerisoli, Chief Executive Officer of Pennant. "By expanding our services and adding

      4/1/25 4:53:37 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care

    $PNTG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by The Pennant Group Inc.

      SC 13G/A - Pennant Group, Inc. (0001766400) (Subject)

      11/14/24 1:28:33 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by The Pennant Group Inc.

      SC 13G/A - Pennant Group, Inc. (0001766400) (Subject)

      11/7/24 9:30:29 AM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by The Pennant Group Inc.

      SC 13G - Pennant Group, Inc. (0001766400) (Subject)

      11/7/24 9:12:22 AM ET
      $PNTG
      Medical/Nursing Services
      Health Care

    $PNTG
    SEC Filings

    See more
    • SEC Form S-8 filed by The Pennant Group Inc.

      S-8 - Pennant Group, Inc. (0001766400) (Filer)

      7/7/25 4:50:48 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • The Pennant Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Pennant Group, Inc. (0001766400) (Filer)

      5/20/25 4:08:35 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by The Pennant Group Inc.

      10-Q - Pennant Group, Inc. (0001766400) (Filer)

      5/6/25 4:12:39 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care